News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Herbert Loong: The safety and feasibility of outpatient administration of tarlatamab as part of the DeLLphi300 study
Herbert Loong/immunooncologyindia.com
Apr 7, 2025, 11:42

Herbert Loong: The safety and feasibility of outpatient administration of tarlatamab as part of the DeLLphi300 study

Herbert Loong, Chair-Elect of the International Affairs Committee at American Society of Clinical Oncology (ASCO), shared an article by A.C. Chiang, et al. on LinkedIn:

“Happy to share our recent ESMO Open paper on the safety and feasibility of outpatient administration of tarlatamab as part of the DeLLphi300 study providing evidence that support less intensive monitoring at initiation of therapy.

Luis Paz-Ares, Noemi Reguart, Shirish Gadgeel and others.”

Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy.

Authors: A.C. Chiang, et al.

Herbert Loong: The safety and feasibility of outpatient administration of tarlatamab as part of the DeLLphi300 study

American Society of Clinical Oncology ASCO cancer DeLLphi300 ESMO Open fight against cancer Global fight against cancer Herbert Loong Luis Paz-Ares Noemi Reguart OncoDaily Oncology Shirish Gadgeel Tarlatamab
Special Coverage
Blog
May 2, 2025, 07:32
National Cancer Centre Singapore Showcases Research at ESTRO 2025
Blog
May 2, 2025, 07:14
Erick Mahatara: Excited to share our very first publication entitled "The silent killer - A story of hypertension"
Blog
May 2, 2025, 06:25
Ssemata Benjamin: Cancer Radiotherapy Must Be Prioritized to Achieve SDG Health Goals
Insight
May 2, 2025, 05:48
Analysis Highlights Multi-Organ Adverse Events from Cancer Immunotherapies - FDA
Blog
May 2, 2025, 05:17
Oguna Kasam: Cancer Survival Should not Depend on Geography
Blog
May 2, 2025, 04:28
Gender Matters: Creating Inclusive and Safer Workspaces - ACREOL Global
Blog
May 2, 2025, 03:47
AI is revolutionizing cancer care - CancerX
Insight
May 2, 2025, 02:54
Stewart O'Callaghan: Lived experience discussion on identity terms in the young adult cancer community
Blog
May 2, 2025, 01:22
Catherine Alix-Panabières: Delighted to have co-moderated the Liquid Biopsy Symposium on CTCs
Oncolibrary
May 2, 2025, 01:01
Tumor Markers: What They Are, How They Help and Their Role in Cancer Care
Blog
May 1, 2025, 20:49
Jennifer Bires: Patients Carrying Private Fears They Were Too Overwhelmed to Share
Blog
May 1, 2025, 20:14
NCI Center for Global Health Highlights Challenges of Conducting Cancer Trials in LMICs